Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 19 | 2025 | 695 | 8.290 |
Why?
|
| Stroke Volume | 12 | 2025 | 370 | 4.170 |
Why?
|
| Exercise | 4 | 2025 | 679 | 1.370 |
Why?
|
| Heart-Assist Devices | 3 | 2019 | 54 | 1.260 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2019 | 22 | 1.180 |
Why?
|
| Exercise Therapy | 4 | 2025 | 271 | 1.170 |
Why?
|
| Clinical Trials as Topic | 3 | 2024 | 307 | 1.100 |
Why?
|
| Patient Participation | 2 | 2017 | 87 | 1.020 |
Why?
|
| Humans | 28 | 2025 | 32779 | 0.960 |
Why?
|
| Hemodynamics | 4 | 2025 | 162 | 0.960 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2025 | 1462 | 0.940 |
Why?
|
| Tetrazoles | 1 | 2025 | 63 | 0.900 |
Why?
|
| Proteomics | 1 | 2025 | 97 | 0.880 |
Why?
|
| Resistance Training | 1 | 2025 | 77 | 0.870 |
Why?
|
| Exercise Tolerance | 1 | 2025 | 120 | 0.850 |
Why?
|
| Myocardial Infarction | 2 | 2017 | 483 | 0.800 |
Why?
|
| Quality of Life | 3 | 2023 | 961 | 0.770 |
Why?
|
| Cardiovascular Agents | 1 | 2022 | 22 | 0.760 |
Why?
|
| Defibrillators, Implantable | 1 | 2022 | 36 | 0.750 |
Why?
|
| Furosemide | 1 | 2022 | 8 | 0.740 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2023 | 168 | 0.730 |
Why?
|
| Hospitalization | 5 | 2025 | 488 | 0.690 |
Why?
|
| Life Style | 1 | 2023 | 407 | 0.670 |
Why?
|
| Ventricular Function, Left | 4 | 2025 | 252 | 0.670 |
Why?
|
| Aged | 11 | 2025 | 10534 | 0.640 |
Why?
|
| Middle Aged | 9 | 2025 | 12115 | 0.510 |
Why?
|
| Health Behavior | 1 | 2017 | 234 | 0.480 |
Why?
|
| Echocardiography | 3 | 2025 | 182 | 0.440 |
Why?
|
| Female | 10 | 2025 | 20249 | 0.420 |
Why?
|
| Diuretics | 2 | 2023 | 26 | 0.390 |
Why?
|
| Aftercare | 2 | 2023 | 34 | 0.380 |
Why?
|
| Multicenter Studies as Topic | 2 | 2022 | 110 | 0.370 |
Why?
|
| Male | 9 | 2025 | 19624 | 0.370 |
Why?
|
| Disease Progression | 2 | 2025 | 594 | 0.360 |
Why?
|
| Treatment Outcome | 4 | 2025 | 3437 | 0.340 |
Why?
|
| Heart Rate | 2 | 2022 | 343 | 0.330 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2009 | 4 | 0.310 |
Why?
|
| Prognosis | 2 | 2022 | 1544 | 0.280 |
Why?
|
| Oxygen Consumption | 2 | 2025 | 150 | 0.270 |
Why?
|
| Obesity | 2 | 2025 | 1152 | 0.260 |
Why?
|
| Retrospective Studies | 4 | 2024 | 3700 | 0.250 |
Why?
|
| Patient Discharge | 3 | 2023 | 204 | 0.250 |
Why?
|
| Biphenyl Compounds | 1 | 2025 | 20 | 0.230 |
Why?
|
| Cardiovascular System | 1 | 2025 | 46 | 0.230 |
Why?
|
| Drug Combinations | 1 | 2025 | 99 | 0.230 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2025 | 72 | 0.230 |
Why?
|
| Eligibility Determination | 1 | 2024 | 18 | 0.220 |
Why?
|
| Hypoglycemic Agents | 1 | 2025 | 180 | 0.210 |
Why?
|
| Tissue Engineering | 1 | 2009 | 659 | 0.210 |
Why?
|
| Cohort Studies | 2 | 2019 | 1844 | 0.210 |
Why?
|
| Risk Factors | 3 | 2021 | 3974 | 0.200 |
Why?
|
| Heart Transplantation | 1 | 2023 | 48 | 0.200 |
Why?
|
| Digoxin | 1 | 2022 | 4 | 0.190 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2022 | 15 | 0.190 |
Why?
|
| Neprilysin | 1 | 2022 | 31 | 0.190 |
Why?
|
| Sodium | 1 | 2022 | 40 | 0.190 |
Why?
|
| Potassium | 1 | 2022 | 40 | 0.190 |
Why?
|
| Patient Selection | 1 | 2024 | 281 | 0.190 |
Why?
|
| Receptors, Angiotensin | 1 | 2022 | 61 | 0.190 |
Why?
|
| Body Mass Index | 1 | 2025 | 908 | 0.190 |
Why?
|
| Peptide Fragments | 1 | 2025 | 403 | 0.190 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2022 | 11 | 0.180 |
Why?
|
| Research Design | 1 | 2024 | 331 | 0.180 |
Why?
|
| Glucose | 1 | 2022 | 184 | 0.180 |
Why?
|
| Phenotype | 1 | 2023 | 638 | 0.170 |
Why?
|
| Electronic Health Records | 1 | 2022 | 182 | 0.170 |
Why?
|
| Hospital Mortality | 2 | 2019 | 205 | 0.170 |
Why?
|
| Liver Cirrhosis | 1 | 2021 | 82 | 0.170 |
Why?
|
| Benchmarking | 1 | 2019 | 25 | 0.150 |
Why?
|
| Aging | 1 | 2025 | 938 | 0.150 |
Why?
|
| Shock, Cardiogenic | 1 | 2018 | 17 | 0.140 |
Why?
|
| Heart Ventricles | 1 | 2019 | 146 | 0.140 |
Why?
|
| Retirement | 1 | 2017 | 13 | 0.140 |
Why?
|
| Medically Uninsured | 1 | 2017 | 34 | 0.140 |
Why?
|
| Employment | 1 | 2017 | 51 | 0.130 |
Why?
|
| Educational Status | 1 | 2017 | 183 | 0.130 |
Why?
|
| Odds Ratio | 1 | 2017 | 467 | 0.130 |
Why?
|
| Referral and Consultation | 1 | 2017 | 147 | 0.130 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 887 | 0.120 |
Why?
|
| Patient Readmission | 1 | 2017 | 134 | 0.120 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 682 | 0.120 |
Why?
|
| United States | 2 | 2023 | 4108 | 0.120 |
Why?
|
| Sex Factors | 1 | 2017 | 675 | 0.120 |
Why?
|
| Logistic Models | 1 | 2017 | 783 | 0.120 |
Why?
|
| Smoking | 1 | 2017 | 531 | 0.100 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 490 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 1572 | 0.100 |
Why?
|
| Registries | 2 | 2025 | 315 | 0.100 |
Why?
|
| Young Adult | 1 | 2017 | 2730 | 0.080 |
Why?
|
| Adolescent | 1 | 2017 | 3627 | 0.080 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2009 | 13 | 0.080 |
Why?
|
| Polymers | 1 | 2009 | 66 | 0.080 |
Why?
|
| Adult | 2 | 2018 | 9547 | 0.070 |
Why?
|
| Biocompatible Materials | 1 | 2009 | 233 | 0.070 |
Why?
|
| Stem Cells | 1 | 2009 | 314 | 0.060 |
Why?
|
| Animals | 2 | 2025 | 7570 | 0.060 |
Why?
|
| Thinness | 1 | 2025 | 33 | 0.060 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2022 | 30 | 0.050 |
Why?
|
| Rare Diseases | 1 | 2022 | 21 | 0.050 |
Why?
|
| Hospitals | 1 | 2023 | 109 | 0.050 |
Why?
|
| Medicare | 1 | 2023 | 213 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 531 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2023 | 524 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2018 | 102 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2018 | 202 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2023 | 4032 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 1197 | 0.030 |
Why?
|
| Time Factors | 1 | 2018 | 2180 | 0.020 |
Why?
|